VACCA, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 31.089
EU - Europa 9.049
AS - Asia 4.907
SA - Sud America 1.134
AF - Africa 70
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 14
Totale 46.277
Nazione #
US - Stati Uniti d'America 30.989
CN - Cina 2.528
SE - Svezia 2.115
SG - Singapore 1.702
IT - Italia 1.593
RU - Federazione Russa 1.411
DE - Germania 1.061
BR - Brasile 1.033
UA - Ucraina 947
FI - Finlandia 648
GB - Regno Unito 541
FR - Francia 262
BE - Belgio 130
ID - Indonesia 113
IN - India 110
IE - Irlanda 95
HK - Hong Kong 88
VN - Vietnam 80
CA - Canada 66
CZ - Repubblica Ceca 53
NL - Olanda 49
JP - Giappone 39
AT - Austria 36
AR - Argentina 34
IR - Iran 26
KR - Corea 24
TR - Turchia 24
IQ - Iraq 23
UZ - Uzbekistan 22
BD - Bangladesh 21
MX - Messico 19
EC - Ecuador 17
LT - Lituania 17
MA - Marocco 17
PL - Polonia 17
ZA - Sudafrica 16
EG - Egitto 15
EU - Europa 14
PH - Filippine 14
CO - Colombia 13
VE - Venezuela 13
ES - Italia 12
AE - Emirati Arabi Uniti 11
AU - Australia 11
JO - Giordania 11
CL - Cile 9
PK - Pakistan 9
CH - Svizzera 7
DZ - Algeria 6
IL - Israele 6
KG - Kirghizistan 6
OM - Oman 6
PY - Paraguay 6
AL - Albania 5
EE - Estonia 5
MK - Macedonia 5
MY - Malesia 5
NP - Nepal 5
RS - Serbia 5
TW - Taiwan 5
UY - Uruguay 5
BG - Bulgaria 4
KE - Kenya 4
PS - Palestinian Territory 4
AZ - Azerbaigian 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
TN - Tunisia 3
AM - Armenia 2
BJ - Benin 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
LV - Lettonia 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
Totale 46.267
Città #
Fairfield 4.236
Chandler 3.323
Woodbridge 3.077
Ashburn 2.284
Jacksonville 2.200
Houston 1.911
Seattle 1.742
Cambridge 1.588
Nyköping 1.470
Wilmington 1.410
Ann Arbor 1.341
Singapore 964
Roxbury 665
Lawrence 662
Nanjing 611
New York 528
Beijing 453
Des Moines 414
Bari 380
Princeton 322
Inglewood 276
San Diego 198
Boardman 162
Shenyang 156
Brooklyn 154
Nanchang 154
Dearborn 149
Hebei 137
Helsinki 137
Los Angeles 129
Brussels 128
Santa Clara 127
Jiaxing 125
London 117
Tianjin 104
Jakarta 103
Moscow 93
Dublin 91
Grafing 84
Rome 83
Hong Kong 82
Munich 80
Changsha 78
Dong Ket 77
São Paulo 77
Washington 68
Pune 66
Guangzhou 62
Marseille 62
Redwood City 61
Paris 58
Milan 50
Frankfurt am Main 48
Brno 42
Council Bluffs 41
Jinan 41
Toronto 39
Leawood 37
Nuremberg 36
Belo Horizonte 35
Shanghai 32
Augusta 30
Rio de Janeiro 30
Norwalk 29
Falkenstein 27
Hefei 27
Kunming 27
Zhengzhou 27
Auburn Hills 26
Ningbo 26
Kilburn 25
Brescia 21
San Mateo 21
Wuhan 21
Naples 20
Falls Church 19
Grottaglie 19
Tashkent 19
Ardabil 18
Osaka 18
Düsseldorf 17
Florence 17
Ottawa 17
Brasília 16
Catania 16
Curitiba 16
Taizhou 16
Vienna 16
Wuxi 16
Chicago 15
Monmouth Junction 15
Porto Alegre 15
Santa Marinella 15
Campinas 14
The Dalles 14
Triggiano 14
Guayaquil 13
Hounslow 13
Tokyo 13
Manduria 12
Totale 34.210
Nome #
Significato clinico dell’interleuchina-2 (IL-2) e del suo recettore solubile nelle gammapatie monoclonali e nella crioglobulinemia mista essenziale 367
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival 238
Translational impact of novel widely pharmacological characterized mofezolac-derived COX-1 inhibitors combined with bortezomib on human multiple myeloma cell lines viability 174
Central Function for JAM-a in Multiple Myeloma Patients with Extramedullary Disease. 170
Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy 167
Le tecniche immunoenzimatiche in immunoistochimica. L’immunoperossidasi e l’immunofosfatasi alcalina 166
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 150
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 149
Isolation and characterization of neural stem cells from dystrophic mdx mouse 147
18F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders 146
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 143
Role of endothelial cells and fibroblasts in multiple myeloma angiogenic switch 141
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 141
Targeting B-cell non Hodgkin lymphoma: New and old tricks 140
JAM-A as a Prognostic Factor and New Therapeutic Target in Multiple Myeloma 139
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation 136
Myeloma cells act as tolerogenic antigen-presenting cells and induce regulatory T cells in vitro 136
Role of HDL and uric acid in vascular damage in well-controlled 135
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein 134
Analysis of aortic remodeling and stiffness in patients with obstructive sleep apnea syndrome: Preliminary results 134
Microenvironment drug resistance in multiple myeloma: Emerging new players 131
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 130
Erythropoietin is involved in the angiogenic potential of bone marrow macrophages in multiple myeloma 129
Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections 128
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma 128
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 127
Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis 125
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 125
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 123
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 123
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese" 123
Early echocardiographic detection of left ventricular diastolic dysfunction in patients with systemic lupus erythematosus asymptomatic for cardiovascular disease 123
A Mini-Review on Thalidomide: Chemistry, Mechanisms of Action, Therapeutic Potential and Anti-Angiogenic Properties in Multiple Myeloma 123
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 122
Skeletal Metastases of Unknown Primary: Biological Landscape and Clinical Overview 121
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme 120
Management of common variable immunodeficiency by subcutaneous IgG self-administration during pregnancy - a case report 118
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 118
Identify multiple myeloma stem cells: Utopia? 118
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 117
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass 117
A possible role of tryptase in angiogenesis in the brain of mdx mouse, a model of Duchenne muscular dystrophy 116
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 116
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 116
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: Clinical results and effects on microenvironment and neo-angiogenic biomarkers 116
Dendritic cells accumulate in the bone marrow of myeloma patients where they protect tumor plasma cells from CD8+ T-cell killing 115
Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea 113
Multiple Myeloma as a model for the role of bone marrow niches in the control of angiogenesis 113
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 112
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma 111
Neutropenia and G-CSF in lymphoproliferative diseases 111
Cancer Associated Fibroblasts and Tumor Growth: Focus on Multiple Myeloma 110
Halting prosurvival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes Bortezomid resistance in multiple myeloma patients. 110
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients 110
Jejunal overexpression of peptide YY in celiac disease complicated with pneumatosis cystoides intestinalis 109
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers 109
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 109
Dendritic cell maturation in HCV infection: Altered regulation of MHC class I antigen processing-presenting machinery 107
Targeting vasculogenesis to prevent progression in multiple myeloma 107
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality 107
Hemilipin, a novel Hemiscorpius lepturus venom heterodimeric phospholipase A2, which inhibits angiogenesis in vitro and in vivo 106
A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the matrigel assay in vitro 105
Vascular endothelial growth factor and tryptase changes after chemoembolization in hepatocarcinoma patients 105
Correlations between severity of obstructive sleep apnoea and systolic pulmonary artery pressure: preliminary results 105
Pharmacological activation of protein phosphatase 2 A (PP2A): A novel strategy to fight against human malignancies? 104
Bone marrow fibroblasts parallel multiple myeloma progression in patients and mice: In vitro and in vivo studies 103
Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy 103
Phthalimide Derivative Shows Anti-angiogenic Activity in a 3D Microfluidic Model and No Teratogenicity in Zebrafish Embryos 103
The role of the vascular phase in solid tumor growth: a historical review 102
Angiogenesis and anti-angiogenesis in neuroblastoma 102
MHC Class i Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells 102
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. 101
Delayed complete remission in a patient with multiple myeloma 101
Belimumab restores Treg/Th17 balance in patients with refractory systemic lupus erythematosus 101
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 101
null 101
A multiple myeloma that progressed as type i cryoglobulinemia with skin ulcers and foot necrosis: A case report 101
Angiogenesis in neuroblastoma 100
Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature 100
Common variable immunodeficiency and gastric malignancies 100
HB-EGF–EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma 100
Autoimmune uveitis: a retrospective analysis of 104 patients from a tertiary reference center 99
Dyspnea, Fatigue, and Generalized Weakness in a 67-Year-Old Man: Approach to the Patient Between Guidelines and Clinical Judgment 99
Cancer treatment and the KIR–HLA system: an overview 99
Metronomic chemotherapy from rationale to clinical studies: A dream or reality? 99
Angiogenesis during tumor progression in human malignant melanoma 98
Direct-acting antiviral agents in the therapy of hepatitis C virus-related mixed cryoglobulinaemia: a single-centre experience 98
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs 98
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 98
Is the localized seminal plasma hypersensitivity the mucosal aspect of protein contact dermatitis? 98
Angiogenesis and vasculogenesis in multiple myeloma: role of inflammatory cells 97
Vascular Endothelial Growth Factor and its Receptors in Multiple Myeloma 97
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma 97
Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients 97
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 97
Giant cell arteritis: The experience of two collaborative referral centers and an overview of disease pathogenesis and therapeutic advancements 97
Multiple myeloma and mycosis fungoides in the same patient: clinical, immunologic and molecular studies 96
Inflammation and antiangiogenesis in cancer 96
Acute intratoracic gastric volvulus from a diaphragmatic hernia after left splenopancreatectomy: report of a case 96
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression 95
Totale 11.956
Categoria #
all - tutte 227.693
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227.693


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.180 0 0 0 0 0 0 0 0 0 0 864 316
2020/20217.125 577 411 560 480 1.039 384 591 528 638 880 547 490
2021/20224.965 301 658 73 208 246 285 283 268 298 372 812 1.161
2022/20238.048 1.187 877 503 746 856 1.162 87 824 1.407 66 181 152
2023/20243.025 254 540 167 183 279 906 92 150 17 77 46 314
2024/20256.874 338 192 1.073 474 339 1.005 1.047 1.127 557 663 59 0
Totale 47.992